5i3o: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "5i3o" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 5i3o is ON HOLD | The entry 5i3o is ON HOLD until Mar 09 2017 | ||
Authors: Counago, R.M., Sorrell, F.J., Krojer, T., Elkins, J.M., Gileadi, O., Willson, T.M., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Arruda, P., Structural Genomics Consortium (SGC) | Authors: Counago, R.M., Sorrell, F.J., Krojer, T., Elkins, J.M., Gileadi, O., Willson, T.M., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Arruda, P., Structural Genomics Consortium (SGC) | ||
Revision as of 13:20, 2 March 2016
Unreleased structure
The entry 5i3o is ON HOLD until Mar 09 2017
Authors: Counago, R.M., Sorrell, F.J., Krojer, T., Elkins, J.M., Gileadi, O., Willson, T.M., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Arruda, P., Structural Genomics Consortium (SGC)
Description: Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor
